Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.

Roux-en-Y gastric bypass (RYGB) is an effective method to attain sustained weight loss and diabetes remission. We aimed to elucidate early changes in the plasma metabolome and lipidome after RYGB. Plasma samples from 16 insulin-resistant morbidly obese subjects, of whom 14 had diabetes, were subject...

Full description

Bibliographic Details
Main Authors: Tulika Arora, Vidya Velagapudi, Dimitri J Pournaras, Richard Welbourn, Carel W le Roux, Matej Orešič, Fredrik Bäckhed
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4422729?pdf=render
id doaj-24487df0fb0a4b29918720149134b157
record_format Article
spelling doaj-24487df0fb0a4b29918720149134b1572020-11-25T01:01:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012640110.1371/journal.pone.0126401Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.Tulika AroraVidya VelagapudiDimitri J PournarasRichard WelbournCarel W le RouxMatej OrešičFredrik BäckhedRoux-en-Y gastric bypass (RYGB) is an effective method to attain sustained weight loss and diabetes remission. We aimed to elucidate early changes in the plasma metabolome and lipidome after RYGB. Plasma samples from 16 insulin-resistant morbidly obese subjects, of whom 14 had diabetes, were subjected to global metabolomics and lipidomics analysis at pre-surgery and 4 and 42 days after RYGB. Metabolites and lipid species were compared between time points and between subjects who were in remission and not in remission from diabetes 2 years after surgery. We found that the variables that were most discriminatory between time points were decanoic acid and octanoic acid, which were elevated 42 days after surgery, and sphingomyelins (18:1/21:0 and 18:1/23:3), which were at their lowest level 42 days after surgery. Insulin levels were lower at 4 and 42 days after surgery compared with pre-surgery levels. At 4 days after surgery, insulin levels correlated positively with metabolites of branched chain and aromatic amino acid metabolism and negatively with triglycerides with long-chain fatty acids. Of the 14 subjects with diabetes prior to surgery, 7 were in remission 2 years after surgery. The subjects in remission displayed higher pre-surgery levels of tricarboxylic acid cycle intermediates and triglycerides with long-chain fatty acids compared with subjects not in remission. Thus, metabolic alterations are induced soon after surgery and subjects with diabetes remission differ in the metabolic profiles at pre- and early post-surgery time points compared to patients not in remission.http://europepmc.org/articles/PMC4422729?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Tulika Arora
Vidya Velagapudi
Dimitri J Pournaras
Richard Welbourn
Carel W le Roux
Matej Orešič
Fredrik Bäckhed
spellingShingle Tulika Arora
Vidya Velagapudi
Dimitri J Pournaras
Richard Welbourn
Carel W le Roux
Matej Orešič
Fredrik Bäckhed
Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
PLoS ONE
author_facet Tulika Arora
Vidya Velagapudi
Dimitri J Pournaras
Richard Welbourn
Carel W le Roux
Matej Orešič
Fredrik Bäckhed
author_sort Tulika Arora
title Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
title_short Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
title_full Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
title_fullStr Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
title_full_unstemmed Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
title_sort roux-en-y gastric bypass surgery induces early plasma metabolomic and lipidomic alterations in humans associated with diabetes remission.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Roux-en-Y gastric bypass (RYGB) is an effective method to attain sustained weight loss and diabetes remission. We aimed to elucidate early changes in the plasma metabolome and lipidome after RYGB. Plasma samples from 16 insulin-resistant morbidly obese subjects, of whom 14 had diabetes, were subjected to global metabolomics and lipidomics analysis at pre-surgery and 4 and 42 days after RYGB. Metabolites and lipid species were compared between time points and between subjects who were in remission and not in remission from diabetes 2 years after surgery. We found that the variables that were most discriminatory between time points were decanoic acid and octanoic acid, which were elevated 42 days after surgery, and sphingomyelins (18:1/21:0 and 18:1/23:3), which were at their lowest level 42 days after surgery. Insulin levels were lower at 4 and 42 days after surgery compared with pre-surgery levels. At 4 days after surgery, insulin levels correlated positively with metabolites of branched chain and aromatic amino acid metabolism and negatively with triglycerides with long-chain fatty acids. Of the 14 subjects with diabetes prior to surgery, 7 were in remission 2 years after surgery. The subjects in remission displayed higher pre-surgery levels of tricarboxylic acid cycle intermediates and triglycerides with long-chain fatty acids compared with subjects not in remission. Thus, metabolic alterations are induced soon after surgery and subjects with diabetes remission differ in the metabolic profiles at pre- and early post-surgery time points compared to patients not in remission.
url http://europepmc.org/articles/PMC4422729?pdf=render
work_keys_str_mv AT tulikaarora rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT vidyavelagapudi rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT dimitrijpournaras rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT richardwelbourn rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT carelwleroux rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT matejoresic rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
AT fredrikbackhed rouxenygastricbypasssurgeryinducesearlyplasmametabolomicandlipidomicalterationsinhumansassociatedwithdiabetesremission
_version_ 1725207975770980352